Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Giant Biogene Holding Co. Ltd. ( (HK:2367) ).
Giant Biogene Holding Co., Ltd has announced the composition of its board of directors and their respective roles within the company. The board includes both executive and independent non-executive directors, with various members serving on key committees such as the Audit, Nomination, Remuneration, and Corporate Governance Committees. This announcement provides clarity on the governance structure of the company, which is crucial for stakeholders to understand the leadership dynamics and decision-making processes within Giant Biogene.
The most recent analyst rating on (HK:2367) stock is a Hold with a HK$63.00 price target. To see the full list of analyst forecasts on Giant Biogene Holding Co. Ltd. stock, see the HK:2367 Stock Forecast page.
More about Giant Biogene Holding Co. Ltd.
Average Trading Volume: 13,785,406
Technical Sentiment Signal: Hold
Current Market Cap: HK$61.23B
For a thorough assessment of 2367 stock, go to TipRanks’ Stock Analysis page.